Search & Analyze
Popular Searches
Natco Pharma Ltd.
Healthcare₹926.300.68%
24 Jul, 4:01 PM
CMP₹926.30
Mkt Cap₹16.46K Cr
P/E11.60
P/B1.78
ROE27.98%
52W High₹1,217.40
52W Low₹789.30
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
11.60
P/B Ratio
1.78
EV/EBITDA
9.00
Price/Sales
4.04
Dividend Yield (%)
0.54
EPS (TTM ₹)
79.20
Book Value (₹)
514.83
ROE (%)
27.98
ROCE (%)
32.85
ROA (%)
24.35
EBITDA Margin (%)
46.05
Net Profit Margin (%)
39.54
Debt/Equity
0.04
Current Ratio
5.59
Interest Coverage
96.87
Asset Turnover
0.62
Working Capital/Sales
1.10
Core EBITDA Growth (%)
35.70
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 20521 | 19448 | 27071 | 39988 | 44295 |
| Net Sales | 20521 | 19448 | 27071 | 39988 | 44295 |
| Total Income | 21581 | 20438 | 28356 | 41269 | 47862 |
| Total Expenditure | 14483 | 16813 | 17954 | 22474 | 22357 |
| Operating Profit | 7098 | 3625 | 10402 | 18795 | 25505 |
| Depreciation | 1169 | 1426 | 1638 | 1868 | 2352 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 5796 | 2022 | 8619 | 16735 | 22914 |
| Tax | 1372 | 322 | 1466 | 2852 | 4080 |
| Profit After Tax (PAT) | 4424 | 1700 | 7153 | 13883 | 18834 |
| EPS (₹) | 24.2 | 9.32 | 39.18 | 77.34 | 105.26 |
| Dividend Payout % | 262.5 | 225 | 275 | 475 | 300 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 365 | 365 | 365 | 358 | 358 |
| Reserves | 40676 | 42237 | 48373 | 58173 | 75712 |
| Shareholders Funds | 41216 | 42636 | 48738 | 58531 | 76070 |
| Total Debt | 2658 | 4040 | 1650 | 3632 | 2731 |
| Total Liabilities | 47919 | 51091 | 56574 | 68869 | 85807 |
| Total Assets | 47919 | 51091 | 56574 | 68869 | 85807 |
| Book Value / Share | 224.8822 | 233.4356 | 267.0575 | 326.9888 | 424.9721 |
| Assets | 47919 | 51091 | 56574 | 68869 | 85807 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 2988 | 465 | 8491 | 12116 | 16968 |
| Investing Activities | -1033 | -53 | -4771 | -10327 | -14145 |
| Financing Activities | -1857 | 348 | -3630 | -2469 | -2107 |
| Net Cash Flow | 98 | 760 | 90 | -680 | 716 |
NATCOPHARM
₹926.30
+0.68%